1-8 of 8
J.E. Hamer-Maansson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Longitudinal genomic shifts associated with disease transformation in patients with polycythemia vera (PV) enrolled in REVEAL

Free
Stephen Oh, Michael Grunwald, TaeHyung (Simon) Kim, Erin Crowgey, J.E. Hamer-Maansson, Ahmad Naim, Valkal Bhatt, Jeffrey Zwicker
Journal: Blood
Blood (2025) 146 (Supplement 1): 3749.
https://doi.org/10.1182/blood-2025-3749
Published: 2025
Journal Articles

Risk factors for progressive kidney impairment among patients with polycythemia vera (PV) are recapitulated and treatable in mouse models of PV

Free
Brandi Reeves, Marcelo Szymanski de Toledo, Fatima Trebak, Malgorzata Kasztan, Vimal Derebail, Rafal Pawlinski, Steffen Koschmieder, J.E. Hamer-Maansson, Ahmad Naim, Valkal Bhatt
Journal: Blood
Blood (2025) 146 (Supplement 1): 605.
https://doi.org/10.1182/blood-2025-605
Published: 2025
Journal Articles

Identification of biomarkers to predict disease progression via molecular analysis of patients (pts) with low-risk myelofibrosis (MF) enrolled in the MOST study

Free
Naveen Pemmaraju, Ellen Ritchie, John Mascarenhas, Salman Fazal, Erin Crowgey, TaeHyung (Simon) Kim, J.E. Hamer-Maansson, Tricia Kalafut, Evan Braunstein, Abdulraheem Yacoub
Journal: Blood
Blood (2025) 146 (Supplement 1): 5526.
https://doi.org/10.1182/blood-2025-5526
Published: 2025
Journal Articles

Molecular Predictors of Disease Progression to Myelofibrosis (MF) in Patients (Pts) with Polycythemia Vera (PV) Enrolled in Reveal

Free
Stephen T. Oh, Jeffrey I. Zwicker, Kamal Patel, Erin L. Crowgey, Cynthia Timmers, Patricia Feldman, Justine Carl, J.E. Hamer-Maansson, Valkal Bhatt, Evan M. Braunstein, Michael R. Grunwald
Journal: Blood
Blood (2024) 144 (Supplement 1): 3145.
https://doi.org/10.1182/blood-2024-199195
Published: 2024
Journal Articles

Clinical and Molecular Characterization of Disease Progression in Patients (Pts) with Low-Risk Myelofibrosis (MF) Enrolled in the MOST Study

Free
Abdulraheem Yacoub, Ellen K. Ritchie, Naveen Pemmaraju, Richard Zuniga, Erin L. Crowgey, Cynthia Timmers, Patricia Feldman, J.E. Hamer-Maansson, Tricia Kalafut, Evan M. Braunstein, John O. Mascarenhas
Journal: Blood
Blood (2024) 144 (Supplement 1): 3136.
https://doi.org/10.1182/blood-2024-199810
Published: 2024
Journal Articles

Disease Progression and Leukemic Transformation in Patients With Lower-Risk Myelofibrosis (MF): An Analysis from MOST

Free
Rami S. Komrokji, Michael R. Grunwald, Evan Braunstein, J.E. Hamer-Maansson, Patricia Kalafut, John Mascarenhas
Journal: Blood
Blood (2022) 140 (Supplement 1): 6832–6834.
https://doi.org/10.1182/blood-2022-159181
Published: 2022
Journal Articles

A Real-World Evaluation of the Association between Elevated Blood Counts and Thrombotic Events in Polycythemia Vera (Analysis of Data from the REVEAL Study)

Free
Aaron T. Gerds, Ruben A. Mesa, John M. Burke, Michael R. Grunwald, Brady Lee Stein, Robyn Scherber, Jingbo Yu, J.E. Hamer-Maansson, Stephen Oh
Journal: Blood
Blood (2021) 138 (Supplement 1): 239.
https://doi.org/10.1182/blood-2021-148509
Published: 2021
Journal Articles

Does Early Intervention in Myelofibrosis Impact Outcomes? a Pooled Analysis of the Comfort I and II Studies

Free
Srdan Verstovsek, Jean-Jacques Kiladjian, Alessandro M. Vannucchi, Ruben A. Mesa, Robyn Scherber, J.E. Hamer-Maansson, Claire N. Harrison
Journal: Blood
Blood (2021) 138 (Supplement 1): 1505.
https://doi.org/10.1182/blood-2021-150894
Published: 2021